TY - JOUR
T1 - Risk of major organ involvement in Behçet's patients with mucocutaneous onset
T2 - Data from the AIDA Network Registry
AU - Vitale, Antonio
AU - Gavioli, Francesco
AU - Caggiano, Valeria
AU - Sbalchiero, Jessica
AU - Lopalco, Giuseppe
AU - Ragab, Gaafar
AU - Guerriero, Silvana
AU - Almaglouth, Ibrahim
AU - Tufan, Abdurrahman
AU - Giacomelli, Roberto
AU - Direskeneli, Haner
AU - Ruscitti, Piero
AU - Hatemi, Gülen
AU - Carubbi, Francesco
AU - Batu, Ezgi Deniz
AU - Ozen, Seza
AU - Sota, Jurgen
AU - Giardini, Henrique Ayres Mayrink
AU - Frassi, Micol
AU - Sfikakis, Petros P.
AU - Iannone, Florenzo
AU - Morrone, Maria
AU - Ghanema, Mahmoud
AU - Saad, Moustafa Ali
AU - Dammacco, Rosanna
AU - Kucuk, Hamit
AU - Kardas, Riza Can
AU - Cakir, Ibrahim Yahya
AU - Navarini, Luca
AU - Alibaz Öner, Fatma
AU - Sevik, Gizem
AU - Gentile, Martina
AU - Karakoc, Alican
AU - Alunno, Alessia
AU - Ercan Emreol, Hulya
AU - Crisafulli, Francesca
AU - Fragoulis, George
AU - Ciccia, Francesco
AU - Thabet, Maissa
AU - Bugatti, Serena
AU - Milanesi, Alessandra
AU - Chimenti, Maria Sole
AU - Monosi, Benedetta
AU - Piga, Matteo
AU - Floris, Alberto
AU - Hinojosa-Azaola, Andrea
AU - Guaracha-Basañez, Guillermo Arturo
AU - Chighizola, Cecilia Beatrice
AU - Hernández-Rodríguez, José
AU - De-La-Torre, Alejandra
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.
PY - 2026/2/1
Y1 - 2026/2/1
N2 - Objectives The progression of Behçet's disease (BD) from a mucocutaneous-limited form to major organ involvement (MOI) represents a significant challenge. This study aims to identify patients without MOI at BD onset who are at increased risk of developing MOI in later stages. Methods Patients' data were drawn from the International AutoInflammatory Disease Alliance (AIDA) Network registry dedicated to BD. Results A total of 328 patients with exclusively mucocutaneous manifestations at BD onset were enrolled. Of these, 82 patients (25%) developed MOI over the entire follow-up period. Patients with minor oral aphthosis and no major oral aphthosis exhibited a reduced risk of developing MOI, with an odds ratio (OR) of 0.41 [95% confidence interval (95%CI): 0.22-0.79, P = 0.008]. Conversely, patients with both major and minor oral aphthosis had a significantly higher risk of developing MOI, with an OR of 12.76 (95%CI: 1.44-113, P = 0.02). Moreover, the development of MOI was associated with major oral aphthosis plus genital aphthosis (OR: 2.49, 95%CI: 1.1-5.6, P = 0.03), major oral aphthosis plus pseudofolliculitis (OR: 2.9, 95%CI: 1.15-7.4, P = 0.02) and major oral aphthosis plus both genital aphthosis and pseudofolliculitis (OR: 3.73, 95%CI: 1.22-11.4, P = 0.02). A positive family history for BD was associated with MOI (OR: 2.85, 95%CI: 1.08-7.58, P = 0.03). Conclusion A positive family history and the presence of major oral aphthosis combined with minor oral aphthosis, genital aphthosis or pseudofolliculitis are associated with MOI development in patients with mucocutaneous BD at onset.
AB - Objectives The progression of Behçet's disease (BD) from a mucocutaneous-limited form to major organ involvement (MOI) represents a significant challenge. This study aims to identify patients without MOI at BD onset who are at increased risk of developing MOI in later stages. Methods Patients' data were drawn from the International AutoInflammatory Disease Alliance (AIDA) Network registry dedicated to BD. Results A total of 328 patients with exclusively mucocutaneous manifestations at BD onset were enrolled. Of these, 82 patients (25%) developed MOI over the entire follow-up period. Patients with minor oral aphthosis and no major oral aphthosis exhibited a reduced risk of developing MOI, with an odds ratio (OR) of 0.41 [95% confidence interval (95%CI): 0.22-0.79, P = 0.008]. Conversely, patients with both major and minor oral aphthosis had a significantly higher risk of developing MOI, with an OR of 12.76 (95%CI: 1.44-113, P = 0.02). Moreover, the development of MOI was associated with major oral aphthosis plus genital aphthosis (OR: 2.49, 95%CI: 1.1-5.6, P = 0.03), major oral aphthosis plus pseudofolliculitis (OR: 2.9, 95%CI: 1.15-7.4, P = 0.02) and major oral aphthosis plus both genital aphthosis and pseudofolliculitis (OR: 3.73, 95%CI: 1.22-11.4, P = 0.02). A positive family history for BD was associated with MOI (OR: 2.85, 95%CI: 1.08-7.58, P = 0.03). Conclusion A positive family history and the presence of major oral aphthosis combined with minor oral aphthosis, genital aphthosis or pseudofolliculitis are associated with MOI development in patients with mucocutaneous BD at onset.
UR - https://www.scopus.com/pages/publications/105031459117
UR - https://www.scopus.com/pages/publications/105031459117#tab=citedBy
U2 - 10.1093/rheumatology/keaf613
DO - 10.1093/rheumatology/keaf613
M3 - Research Article
C2 - 41259668
AN - SCOPUS:105031459117
SN - 1462-0324
VL - 65
JO - Rheumatology
JF - Rheumatology
IS - 2
M1 - keaf613
ER -